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Abstract 
Isoprenoids form an extensive group of natural products involved in a number of important 
biological processes. Their biosynthesis proceeds through sequential 1’-4 condensations of 
isopentenyl diphosphate (C5) with an allylic acceptor, the first of which is dimethylallyl 
diphosphate (C5). The reactions leading to the production of geranyl diphosphate (C10), 
farnesyl diphosphate (C15) and geranylgeranyl diphosphate (C20), which are the precursors of 
mono-, sesqui- and diterpenes, respectively, are catalyzed by a group of highly conserved 
enzymes known as short-chain isoprenyl diphosphate synthases or prenyltransferases. In 
recent years, the sequences of many new prenyltransferases have become available, including 
those of several plant and animal geranyl diphosphate synthases, revealing novel mechanisms 
of product chain-length selectivity and an intricate evolutionary path from a putative, common 
ancestor. Finally, there is considerable interest in designing inhibitors specific to short-chain 
prenyltransferases, for the purpose of developing new drugs or pesticides that target the 





With more than 55,000 compounds identified in bacteria, archea and eukaryotes, isoprenoids 
are the most abundant and structurally diverse natural products. They play essential roles in 
numerous biochemical pathways: as quinones in electron transport chains, as components of 
membranes (prenyllipids in archaebacteria and sterols in eubacteria and eukaryotes), in 
subcellular targeting and regulation (prenylation of proteins), as photosynthetic pigments 
(carotenoids, side chain of chlorophyll), as hormones (gibberellins, brassinosteroids, abscisic 
acid, retinoic acid, juvenile hormone), and as semiochemical compounds in plants and insects 
(monoterpenes, sesquiterpenes, diterpenes) [1,2]. 
The universal precursors of isoprenoids generated by the mevalonate pathway are 
synthesized by sequential 1’-4 condensations of isopentenyl diphosphate (IPP, C5) with an 
allylic diphosphate, in reactions catalyzed by enzymes commonly referred to as 
prenyltransferases or isoprenyl diphosphate synthases (IPPS). Each member of this enzyme 
family is classified according to the stereochemistry of the double bonds formed during 
product elongation and the length of the final product [3]. In general, trans-prenyltransferases 
synthesize products up to C50 in length, with trans (E) double bonds, while most cis-
prenyltransferases characterized to date generate longer products featuring cis (Z) double 
bonds. Although trans- and cis-prenyltransferases catalyze similar reactions, they are 
evolutionary and structurally distinct [4]. Trans-prenyltransferases can be further divided into 
short-chain (SCIPPS; C10–C25), medium-chain (MCIPPS; C30–C35), and long-chain (LCIPPS; 
C40–C50) prenyltransferases [3]. Whereas most short-chain prenyltransferases are active as 





Enzymes of the short-chain prenyltransferase subfamily 
Geranyl diphosphate synthase (GPP synthase or GPPS): GPPS catalyzes the condensation of 
two C5 co-substrates, IPP and dimethylallyl diphosphate (DMAPP), to produce GPP, the 
precursor of all monoterpenes (Fig. 1). Despite the multiple functions of monoterpenes, which 
are found most commonly in plants and insects where they act as essential oils and 
pheromones, respectively, our understanding of their biosynthesis remains limited. GPPS 
genes have been characterized from only a handful of plant species [5-13] and, so far, only 
one study has reported on the existence of a GPPS in an insect [14]. However, a second 
putative GPPS has recently been cloned by our group from a longhorn beetle (unpublished 
data; see Evolution of short-chain prenyltransferases for more information), and an enzyme 
producing both GPP and FPP has been cloned from aphids [15,16]. Based on sequence 
comparisons, three different classes of plant GPPSs may be distinguished, one of which 
contains heterodimeric proteins, while the other two are active as homodimers [13]. In the 
first heterodimeric GPPS to have been isolated (from Mentha piperita), the two subunits were 
shown to display very limited similarity to one another, with only one subunit recognized as a 
typical prenyltransferase [6]. Among the homodimeric plant GPPSs, one class has so far been 
found only in conifers [13] while the other class has members among diverse plant species, 
including Arabidopsis thaliana [8]. These two homodimeric GPPS types display only 20% 
amino acid sequence identity to each other. The first GPPS to be characterized from an animal 
was isolated from the bark beetle Ips pini, in which it plays a role in aggregation pheromone 
biosynthesis [14]. Plant and insect GPPSs appear to have no common proximate ancestor (see 
Evolution of short-chain prenyltransferases). 
 
Farnesyl diphosphate synthase (FPP synthase or FPPS): FPPS is the most extensively 
studied short-chain prenyltransferase due to its central position in the mevalonate pathway. 
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FPPS catalyzes the condensation of IPP and DMAPP to form the intermediate GPP, which 
then endergoes a second condensation step to generate FPP (Fig. 1). The FPP product serves 
as precursor to sesquiterpenes, sterols, dolichols, and some mitochondrial ubiquinones, and is 
used for protein farnesylation. FPPSs were purified to homogeneity from a number of 
organisms, including Saccharomyces cerevisiae [17], chicken [18], pig [19], human [20], and 
green pepper, Capsicum annuum [21]. All of these purified enzymes were found to form 
homodimers, with tightly coupled subunits ranging from 32 to 44 kDa in size. In addition, 
FPPS cDNAs were cloned from various organisms [22-31]. FPPSs may be divided into two 
broad categories: type I (eukaryotic) and type II (eubacterial) FPPSs [32,33]. Recent work on 
insect FPPSs suggests that the type-I enzymes include various subtypes displaying features 
that are distinct from those of vertebrate, plant and yeast FPPSs [27,34]. 
In addition to the trans-FPPSs described above, some cis-FPPSs have recently been 
cloned and characterized from bacteria [35-37] and plants [38]. Whereas the bacterial 
enzymes use GPP as allylic co-substrate and produce E,Z-FPP, the plant enzyme uses 
DMAPP and generates Z,Z-FPP. Little is known about the mechanism of product chain 
lentgth regulation in these enzymes [37,38].  
 
Geranylgeranyl diphosphate synthase (GGPP synthase or GGPPS): GGPPS supplies the 
essential acyclic precursor GGPP for the biosynthesis of a structurally diverse group of 
compounds that includes diterpenes, carotenoids, chlorophylls, geranylgeranylated proteins 
and archaeal ether-linked lipids. In plants and bacteria, GGPP is synthesized by a GGPPS that 
catalyzes successive additions of IPP to DMAPP, GPP, and FPP (Fig. 1), while yeast and 
mammalian GGPPSs can only accept FPP as the allylic co-substrate [39]. To date, cDNAs 
encoding GGPPS have been cloned from various organisms ranging from bacteria to higher 
eukaryotes [40-46]. GGPPSs have been divided into three categories [32,33]:  type I (archaea 
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and some bacteria), type II (plants and bacteria), and type III (eukaryotes other than plants) 
(see Evolution of short-chain prenyltransferases for further details). 
 
Farnesylgeranyl diphosphate synthase (FGPP synthase or FGPPS): Tashibana [47] reported 
on the presence of farnesylgeranyl diphosphate (FGPP) synthase activity, generating C25 
isoprenyl diphosphates, in Natronobacterium pharaonis, a haloalkaliphilic archaeon that has 
C20-C25 diether lipids in its membranes, in addition to the C20-C20 diether lipids commonly 
found in archaea. The highest activity of this FGPPS was observed when GGPP was used as 
the allylic substrate. Tashibana  et al. [48] observed the same behavior for an FGPPS from the 
aerobic hyperthermophilic archaeon Aeropyrum pernix, the membrane of which contains only 
C25-C25 diether lipids. These archeal FGPPSs are very closely related to archeal GGPPSs [48], 
thus justifying their inclusion here in the group of short-chain prenyltransferases (see also 
Evolution of short-chain prenyltransferases). 
 
Short-chain prenyltransferases displaying “catalytic promiscuity”: short-chain 
prenyltransferases displaying dual FPP/GGPP synthase activity have been reported for a 
protozoan [49], a hyperthermophilic archaea [50], and maize [51]. In the reactions catalyzed 
by these enzymes, the use of either DMAPP or GPP as allylic co-substrate leads to the 
formation of both FPP and GGPP, whereas the use of FPP generates GGPP as the sole 
product. This is in contrast with results obtained for conventional GGPPSs, which tend to 
generate only GGPP, irrespective of the allylic co-substrate used. 
In aphids, Vandermoten et al. [15] identified the first animal short-chain 
prenyltransferase that can generate both GPP and FPP. Although the recombinant enzyme 
yielded more GPP than FPP, and the proportion of GPP increased with a rise in the 
concentration of DMAPP, it generated only FPP if supplied with GPP as the sole allylic co-
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substrate [15]. In addition, the recombinant aphid enzyme could generate both monoterpenes 
and sesquiterpenes in linked assays where appropriate terpene synthases were added to the 
assay buffer [16]. In contrast, the recombinant Drosophila melanogaster FPPS generated 
almost exclusively FPP in the presence of IPP and DMAPP [15]. 
In Norway spruce, Picea abies, Shimdt et al. [13] reported on the presence of two 
GPPSs belonging to two separate groups of homodimeric proteins. While one enzyme 
produced GPP as its sole in vitro product, the second enzyme produced substantial amounts of 
FPP and GGPP, in addition to GPP (42% GPP, 33% FPP, and 25% GGPP). In parallel assays 
performed on a related enzyme from the angiosperm Quercus robur, GPP and FPP were 
produced in proportions of 55 to 45, while no GGPP was detected [13]. 
These dual (or multiple) activities observed for some short-chain prenyltransferases 
may be examples of “catalytic promiscuity”, an expression that was coined to describe the 
ability of some enzymes to display an adventitious secondary activity at the active site 
responsible for the primary activity [52]. Catalytic promiscuity is of interest because an 
adventitious secondary activity may become useful to the organism at some point, and the 
enzyme may be recruited to provide the secondary product. For example, the existence of a 
GPP/FPP synthase in aphids is perhaps not too surprising, given that these insects require 
both monoterpenes and sesquiterpenes as precursors for sex pheromone, alarm pheromone 
and juvenile hormone biosynthesis [15]. 
 
Catalytic mechanism 
Short-chain prenyltransferases catalyse chain elongation reactions, where the growing chain 
of an allylic isoprenoid diphosphate (DMAPP, GPP or FPP) undergoes coupling with IPP 
through electrophilic alkylation of its carbon-carbon double bond. In all organisms, this 
reaction occurs following a sequential ionization-condensation-elimination mechanism 
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referred to as head-to-tail condensation. After binding of both co-substrates to the enzyme, a 
carbocation is formed at the C1’ position of the allylic substrate; this step is activated by 
divalent cations such as Mg2+ or Mn2+. The carbocation electrophilically attacks the C4 
position of IPP resulting in formation of a C-C bond between IPP and the allylic substrate. 
The product is then released from the active site [53]. The stereochemistry of the 1’-4 
condensation was elucidated by Cornforth’s group [54], who established that the allylic 
carbocation attacks the double bond of IPP from the Si-face. The proR-H at the C2 position of 
IPP is then removed to form a new allylic trans-double bond 
 
Structure and active site 
Current knowledge about short-chain prenyltransferase 3D-structures is based in large part on 
the work of Tarshis et al., who reported the crystal structure of unliganded avian FPPS at 2.6-
A˚ resolution [55], as well as that of the corresponding double F112A/F113S mutant, liganded 
with DMAPP, GPP, and FPP [56]. More recently, Hosfield et al. [57] reported the crystal 
structures of two prokaryotic FPPSs at 2.4-A˚ resolution: the unliganded Staphylococcus 
aureus FPPS and the Escherichia coli enzyme bound to both IPP and a noncleavable DMAPP 
analogue. In addition, the structure of the Trypanosoma cruzi FPPS, both unliganded and 
complexed with substrates and inhibitors, has been elicidated [58]. Furthermore, Kavanaght et 
al. [59] reported the high-resolution X-ray structures of the human FPPS in complex with two 
bisphosphonate inhibitors, risedronate and zoledronate, respectively. Finally, Chang et al. 
reported the first GGPPS structure, which was determined for the yeast Saccharomyces 
cerevisiae at 1.98-A˚ resolution [60]. 
Altogether, these studies have indicated that short-chain prenyltransferases are 
typically active as homodimers and exhibit a fold composed of 13 α-helices joined by loops. 
Ten of these helices form a helical bundle that surrounds a central cavity where the active site 
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is located. Two highly conserved aspartate-rich motifs face each other on opposite walls of 
this cavity. Using hybrid-type heterodimers of Bacillus stearothermophilus FPPSs, 
constituting different types of mutated monomers in regions II and IV (see below), Koyama et 
al. suggested that FPPS subunits interact with each other to form a shared active site in the 
homodimer structure, rather than an independent active site in each subunit [61]. More 
recently, the determination of the first mammalian GGPPS crystal structure revealed a novel 
hexameric quaternary structure [62]. The regions involved in hexamer formation (from three 
homodimers) are largely conserved for mammalian and insect GGPPSs, but not for plant, 
bacterial, fungal, or archaeal GGPPSs, suggesting that insect GGPPS may be hexameric as 
well. Unlike the homodimeric FPP or GGPP synthases purified to date, both homo- and 
heteromeric forms of plant GPPSs have been identified [6,7,9]. 
The deduced amino acid sequences of all short-chain prenyltransferases tend to display 
a high level of similarity to one another, and multiple sequence alignments have revealed the 
presence of seven conserved regions [63]. Regions II and VI contain aspartate-rich motifs 
(DDx(xx)xD; where x represents any amino acid) referred to as the first (FARM) and second 
(SARM) aspartate-rich motifs, respectively. Site-directed mutagenesis studies targeting the 
aspartate residues within the FARM have pointed to their involvement in catalysis and 
binding of the allylic substrate [63,64]. Binding of IPP, however, involves the C-terminus of 
the enzyme, which interacts with Lys, Arg and His residues contacting the IPP pyrophosphate 
[57]. Among the five residues located upstream from the FARM, some have been shown to be 
involved in product chain-length determination; this portion of the sequence is therefore 
referred to as the chain-length determination (CLD) region [33], although additional residues, 




Mechanisms of product chain-length regulation 
Although they share the same catalytic mechanism, short-chain prenyltransferases rarely 
generate a product whose chain length differs from that which is pre-determined for the 
enzyme. Over the past several years, there has been considerable interest in identifying the 
mechanisms responsible for product chain-length regulation by SCIPPSs. In this context, it has 
been observed that factors such as salt and metal ion concentrations [65,66] and the ratio 
between allylic and IPP co-substrates [15,67,68] can, to a limited extent, modulate the product 
chain-length selectivity of some prenyltransferases. Under certain circumstances, temperature 
can also have an impact on this variable, as shown by Fujiwara et al. [69] for the dual 
FPP/GGPP synthase isolated from the hyperthermophilic archea Thermococcus 
kodakaraensis.  
However, the primary molecular mechanism regulating product chain length is 
dependent upon structural features specific to each subgroup of prenyltransferases. Our 
current understanding of the mechanisms of product chain-length determination by these 
enzymes is derived primarily from the elucidation of their 3D structures, combined with 
several site-directed and random mutagenesis studies. The analysis of the crystal structures of 
wild-type and mutated avian FPPS suggested that the ultimate product length was dictated by 
the size of the active site hydrophobic pocket [56]. More specifically, the two aromatic 
residues Phe112 and Phe113, located at the fourth and fifth positions upstream from the 
FARM, were shown to form the “floor” of the catalytic pocket, and replacement of these two 
amino acids with smaller residues directly altered the size of the binding pocket, resulting in 
the formation of longer products. Additional studies further demonstrated that the product 
chain-length of wild-type FPP and GGPP synthases was in large part determined by the nature 
of the amino-acid residues located at both the fourth and fifth positions upstream from the 
FARM [11,56,70,71]. The side-chains of these amino-acid residues can either prevent or 
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allow additional condensations to take place, with smaller side-chains typically permitting 
further product elongation. In bacterial FPPSs, which typically have a two-amino-acid 
insertion within the FARM (i.e., DDxxxxD instead of DDxxD), only the residue at position 
−5 relative to the FARM seems critical to defining product chain length selectivity [70,71], 
possibly because of the structural changes brought about by the two-amino-acid insertion [33]. 
Residues other than those at positions −4 and −5 relative to the FARM can also play a 
role in the chain-length selectivity of short-chain prenyltransferases. For example, the 
Ala116Trp (−1 relative to the FARM) and Asn144Trp (+23 relative to the FARM) avian 
FPPS mutants displayed a smaller binding pocket for the hydrocarbon chain of the allylic 
substrate, with altered product selectivity favoring synthesis of shorter products such as GPP 
[72]. In type-III GGPPSs, in which the fourth and fifth residues upstream from the FARM are 
either Ser or Ala (Fig. 2), other residues located deeper in the catalytic cavity prevent chain 
elongation beyond C20. In yeast GGPPS, for instance, Tyr107, Phe108 and His139 seal the 
bottom of the active site cavity [60].  
Several insect GPP and FPP synthases do not display an aromatic residue at either or 
both the fourth and fifth positions upstream from the FARM [27]. For example, the aphid 
GPP/FPP synthase displays a Gln residue at positions −4 relative to the FARM 
(YQxxxDDxxD), a feature shared with lepidopteran type-1 FPPSs [27], for which the exact 
product(s) remain(s) to be identified [73]. Site-directed mutagenesis and molecular dynamics 
simulations indicated that  the dual GPP/FPP synthase activity of the aphid enzyme was 
largely defined by Gln107 and Leu110, at positions −4 and −1 relative to the FARM, 
respectively. Although the mechanism responsible for this dual activity involves steric 
constraints on the ligand, as shown for other short-chain prenyltransferases, two additional 
factors have been identified, namely ligand stabilization and the disruption of H-bonds formed 
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between Gln107 and residues across the catalytic cavity, which constitutes a novel chain-
length determination mechanism for SCIPPSs [Vandermoten et al., unpublished data].  
Although the mechanism of product chain-length determination of homodimeric plant 
GPPSs has not been elucidated, that of the heterodimeric GPPS from mint [6] has been shown 
to be dependent upon the interaction of the small subunit with the large, GGPPS-like subunit 
[74]. However, this interaction does not appear to result strictly from constraints imposed by 
the small subunit on the size of the active site cavity in the large subunit [10]. Thus, additional 
geometric features of the catalytic cavity apparently contribute to product chain-length 
determination in these GPPSs. 
 
Evolution of short-chain prenyltransferases 
Phylogenetic trees of trans-isoprenyl diphosphate synthases were published earlier by other 
groups [32,33,48,75], but many prenyltransferases have since been cloned and sequenced, 
including several plant and animal GPPSs, insect FPPSs displaying unusual features and 
various medium- and long-chain polyprenyl diphosphate synthases, to which short-chain 
prenyltransferases are related. For this reason, it seemed appropriate to re-examine the 
phylogeny of this group of enzymes. 
All trans-isoprenyl diphosphate synthases are believed to be derived from a common 
ancestor, and some have argued that archeal GGPPSs are the closest relatives to this common 
ancestor [33,75], although this hypothesis has been challenged [48]. Given the high incidence 
of horizontal gene transfer that has occured among procaryotes [76], it will remain difficult to 
identify the prenyltransferase that is closest to the root of the tree. For this reason, the present 
tree (Fig. 2) was left unrooted; as a result, its branching order may not always reflect the 
evolutionary course that these enzymes have taken. Nevertheless, the analysis clearly 
indicates that trans-isoprenyl diphosphate synthases form two large and distinct clusters that 
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have presumably originated from a common procaryotic ancestor: animal GPPSs and 
eukaryotic FPPSs, on the one hand, and all other trans-prenyltransferases, on the other. 
Within the first cluster, the residues at positions −4 and −5 relative to the FARM tend to be 
aromatic amino acids (F or Y), although this is not always the case, particularly among the 
FPPSs of unicellular organisms such as Plasmodium and Trypanosoma, and the enzymes of 
insects, where substitutions at these positions can lead to the formation of GPP, instead of 
FPP, as the principal product [15]. The level of amino acid sequence similarity among these 
enzymes displays a wide range of variation in pairwise comparisons, even within a species 
(e.g., spruce budworm FPPS1 and FPPS2). Bark beetle GPPS and FPPS are very divergent 
and display only a limited degree of similarity to one another, despite a nearly identical CLD 
region (the GPPS has an uncommon cysteine residue at position −3 relative to the FARM). 
The nature of the residue at the first position upstream from the FARM, which can have an 
impact on product chain length [72], also tends to vary considerably within this group (L, M, I, 
V, A, S or E). In contrast, all enzymes in the other cluster, with the exception of animal and 
type-II bacterial GGPPSs, have a histidine residue at the equivalent position. In fact, many of 
these enzymes, including all eukaryotic polyprenyl diphosphate synthases [PPPSs; i.e., all 
MCIPPSs and LCIPPSs, including those whose exact product chain-length (C30-C50) is 
unknown], a sub-group of plant homodimeric GPPSs, archeal PPPSs, and some bacterial 
medium-chain and long-chain IPPSs share the same ASxxHDDxxD “FARM signature”. The 
ubiquity of this histidine residue suggests that it plays an important structural role, although 
its presence in enzymes displaying vastly different product chain-length selectivities (e.g., 
plant GPPSs and animal LCIPPSs) points to a limited role in defining product chain length. 
Interestingly, animal GGPPSs are closely related to the yeast enzyme (both are type-III 
GGPPSs), while the latter is clearly distinct from plant GGPPSs (Fig. 2). Type-III GGPPSs 
are highly divergent from their intra-specific FPPS counterparts. In fact, inter-taxonomic 
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GGPPS-GGPPS comparisons reveal a much higher degree of similarity than that measured 
for intra-specific FPPS-GGPPS comparisons (e.g., Blastp expect values for human versus 
Drosophila GGPPS: 1e −103; for human FPPS versus human GGPPS: 1e -007). These 
observations strongly suggest that the two enzymes have not evolved from one another, but 
have been acquired independently, possibly through horizontal gene transfer in a common 
ancestor. A more obvious case of the latter phenomenon is seen with plant GGPPSs and a 
sub-group of plant GPPSs, which display a CLD region almost identical to that of some 
bacterial FPPSs and GGPPSs (including the insertion of two extra residues within the FARM), 
from which they appear to have originated (Fig. 2). 
Whereas FPP and GGPP synthases occur nearly ubiquitously in plants, animals, fungi 
and bacteria, GPPSs appear to have a more limited distribution in nature, having been 
identified almost exclusively in plants and insects. The present analysis indicates that insect 
GPPSs have evolved from insect FPPSs while those of plants have evolved once from 
eukaryotic PPPSs (most homodimeric plant GPPSs) and once from plant GGPPSs 
(heterodimeric plant GPPSs). The homodimeric grand fir GPPS stands out from the other 
homodimeric plant GPPSs included in the present analysis, with its distinctive bacterial 
“FARM signature”. Clearly, trans-prenyltransferases from all organisms share many features 
that are indicative of common ancestry, but they also seem to have followed a convoluted 
evolutionary path that blurs some of the branching points in the tree shown here. 
 
Inhibitors of short-chain prenyltransferases and perspectives for applied research 
Over the past several years, there has been considerable interest in developing inhibitors that 
are specific to certain enzymes of the mevalonate pathway. This concept has found 
widespread clinical use with statins, which are drugs that inhibit hydroxymethylglutaryl-CoA 
(HMG CoA) reductase and, as a result, reduce cholesterol biosynthesis. Because short-chain 
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prenyltransferases play a pivotal role in the biosynthesis of numerous mevalonate pathway 
end-products, the inhibition of their activity is also of great interest in applied research. 
Among this enzyme family, FPPS is a key target, and several groups have investigated the 
possibility of inhibiting FPPS with nitrogen-containing bisphosphonates (N-BPs) [77-80]. N-
BPs are pyrophosphate analogs in which the oxygen bridge between the two phosphorus 
atoms has been replaced with a carbon atom bearing two side chains, the nature of which 
affects the compound’s chemical properties, mode of action and potency. 
In mammals, the inhibition of FPPS by N-BPs blocks the formation of FPP, which is 
required for protein prenylation. A deficit in protein prenylation results in osteoclast apoptosis 
and inhibition of the bone-destroying action of these cells [81]. Therefore, N-BPs are used to 
treat disorders characterized by bone resorption such as osteoporosis, Paget disease, 
hypercalcemia caused by malignancy, tumour metastases in bone, and other ailments [82-85]. 
A number of N-BPs have recently been shown to have curative effects in in vivo 
models of visceral [86] and cutaneous [87] leishmaniasis. Their significant activity was also 
demonstrated against the proliferation of T. brucei and T. cruzi, the causative agents of 
African trypanosomiasis (sleeping sickness) and Chagas’ disease, respectively. Other N-BPs 
also show potential as anti-cancer drugs as they can inhibit human GGPPS, which is required 
for the prenylation of proteins such as Ras involved in cancer development [88]. 
In the field of agrochemical research, the replacement of the amino group of N-BPs by 
hydroxyl, ureido, thioureido, or amino moieties leads to compounds inhibiting FPPS and 
having significant herbicidal properties [89]. Some of the N-BPs that are effective in 
inhibiting FPP and GGPP synthases also inhibit plant heterodimeric GPPSs [10]; the 
herbicidal action of N-BPs could therefore result from their inhibitory activity on more than 
one prenyltransferase. It has also been suggested that the uncommon structural features of 
some insect GPP and FPP synthases, including those of caterpillars [27] and aphids [15], 
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could be exploited for the design of pest-specific inhibitors displaying insecticidal activity. 
Since FPPSs are required for the production of juvenile hormone in insects, FPPS inhibition is 
expected to cause a decrease in the production of this hormone, which would result in a 
precocious and lethal metamorphosis [90]. 
 
Conclusion 
Although considerable new information has accumulated on short-chain prenyltransferases 
during the past decade, with important advances in their cloning and characterization, these 
enzymes have not yet revealed all their secrets. Indeed, the recent discovery of new types of 
short-chain prenyltransferases that produce a mixture of products with different chain-lengths 
points to a new level of complexity in the mechanism regulating product size, which is not 
always dictated only by steric constraints, as originally suggested. Many of the recently 
cloned enzymes have yet to be characterized, including several putative insect FPPSs, which 
could turn out to have properties that differ from those initially inferred from blastp searches, 
given the sometimes unorthodox nature of their CLD regions. In addition, the mechanism of 
product chain-length selectivity of homodimeric plant GPPSs, which are in many respects 
very similar to eukaryotic long-chain prenyltransferases, needs to be examined so as to 
identify the substitutions that have led the presumed conversion of enzymes that generate long 
polyprenyl chains into GPPSs; this would help elucidate their exact evolutionary history. 
Finally, there are still exciting prospects with respect to the development of inhibitors 
specific to short-chain prenyltransferases, both in the field of drug discovery and in 
crop/forest protection. Progress in this area will undoubtedly continue to benefit from 
sustained efforts in the structural and enzymatic characterization of novel prenyltransferases 
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Figure 1: Elongation reactions catalyzed by short-chain prenyltransferases, along with 
examples of final products generated by the geranyl diphosphate (GPP), farnesyl diphosphate 
(FPP), geranylgeranyl diphosphate (GGPP), and farnesylgeranyl diphosphate (FGPP) 
precursors.  
 
Figure 2:  Phylogenetic tree (unrooted) of trans-isoprenyl diphosphate synthases from 
diverse taxa. Nucleotide sequences were retrieved from Genbank and imported into MEGA4 
[91], where they were conceptually translated into proteins. Alignments were performed on 
the amino acid sequences using ClustalW, as implemented by MEGA4, with default settings 
except for penalties relating to multiple alignment gap openings and extensions, which were 
set to 3.0 and 1.8, respectively [92]. The back-translated nucleotide alignment was then used 
to construct a Neighbor-Joining tree using MEGA4’s default settings, except for gap deletions, 
where the pairwise deletion option was selected. Bootstrapping was performed on 2000 
pseudoreplicates, and all branches with less than 50% boostrap support were collapsed. For 
each enzyme or enzyme lineage, residues within the chain-length determination (LCD) region 
[i.e., the first aspartate-rich motif (“FARM” = DDxxD or DDxooxD) and the five residues 
upstream from it] are shown as a color-coded sequence, where x = L, I, V or M, and o = any 
amino acid. Residues at position −4 and −5 relative to the FARM are shown in green, while 
25 
 
the residue at position −1 is shown in red. Aspartate residues within the FARM are shown in 
blue.  Accession numbers: GPPS: algae, XM_001691017; Arabidopsis, Y17376; bark beetle, 
AY953508; grand fir, AF513112; longhorn beetle, not deposited yet; Mentha, AF182828; 
spruce; EU432048; tomato, DQ286930; GPPS/FPPS: aphid, AY968586; FPPS: Arabidopsis, 
L46350; bark beetle, AY953507; Drosophila, NM_058032; E. coli, D00694; human, 
NM_002004; Microcccus, AB003187; mosquito, XM_308653; nematode, NM_060626; 
Plasmodium-AY219707; spruce budworm-1, AY954920; spruce budworm-2, AY954919; 
Trypanosoma, AF386102; yeast, NC_001142; FPPS/GGPPS: Methanothermobacter, S75695; 
Mycobacterium, NC_000962; GGPPS: Arabidopsis, NM_127943; Drosophila, AF049659; 
human, NM_004837; Pantoea, D90087; Sulfolobus, NC_007181; Yeast, AY692852; FGPPS: 
Aeropyrum, AB025791; hexaprenyl diphosphate synthase (HPPS; C30): Micrococcus, 
AB003188; heptaprenyl diphosphate synthase (HepPPS; C35): Bacillus, EF191544; 
octaprenyl diphosphate synthase (OPPS; C40): Archeoglobus, AE000782; E. coli, U18997; 
Trypanosoma, XM_799480; solanesyl diphosphate synthase (SPPS): Arabidopsis, 
NM_001084371; mouse, NM_019501; Mucor mold, AJ496300; Rhodobacter, AB001997; 
decaprenyl diphosphate synthase (DPPS; C50): fission yeast, NM_001021183; human, 
NM_014317; PPPS: aphid, XM_001947162; body louse, DS235241; chicken, XM_418592; 
Drosophila, NM_170546; Methanosarcina, NC_007355; mosquito, XM_565746; Plasmodium, 
XM_001349505; Tribolium, XM_968226; wasp, XM_001602302. 
 
